Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States

por Shah, Bijal D., Smith, Nathaniel J., Feng, Chaoling, Jeyakumar, Sushanth, Castaigne, Jean-Gabriel, Faghmous, Imi, Masouleh, Behzad Kharabi, Malone, Daniel C., Bishop, Michael R.
Publicado 2022